DNA Bridges, Inc. is a leading corporate development firm that leverages seasoned scientific and business talent in the life sciences, device and pharmaceutical industries to bridge science and products.

FROM DISCOVERY TO LAUNCH our team has developed and supported the commercialization of products with combined sales over $10 billion USD. These include Herceptin, Xolair, Activase, Raptiva and Kogenate.

Corporate Strategy Fact Sheet Bioprocessing and Manufacturing Fact Sheet Prepare to Meet Your Partner by Cori Gorman, Cammie Edwards and Robert Meister Personalized Medicine Can Increase Revenue by Cammie Edwards

OUR NEWS

July 24-26:  Boston
6th Antibody Engineering & Discovery
The DNA Bridges team member, Dr. Greg Landres will be pre-workshop leader and will give opening remarks on Wednesday, July 25. 
http://antibody-engineering.com/

MORE DNA BRIDGES NEWS

INDUSTRY & CLIENT NEWS

Client News > ADIENNE Signs Agreement w/ Selexis for Development of Novel Fully Human Mini-Antibody http://t.co/vj06sLJh #biotech Wed, 16 May 2012 16:52:39

DNA Bridges @ 6 Antibody Engineering and Discovery in Boston - Greg Landres http://t.co/cTmQNxcD #antibody Mon, 30 Apr 2012 21:56:08

FOLLOW US ON Twitter

© 2010 DNA Bridges, Inc.

Terms and Conditions | Privacy